4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile has been researched along with Prostatic Neoplasms in 2 studies
*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KH; Arai, S; Ishikura, N; Jung, KY; Kawata, H; Nagamuta, M; Nakagawa, T; Nakamura, M; Ohta, M; Onuma, E; Sato, H; Shiraishi, T; Tachibana, K; Yoshino, H | 1 |
| André, J; Foury, O; Joly-Pharaboz, MO; Nicolas, B | 1 |
2 other study(ies) available for 4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile and Prostatic Neoplasms
| Article | Year |
|---|---|
Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists.
Topics: Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Carboxylic Acids; Cell Line, Tumor; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Male; Mice; Mice, SCID; Molecular Structure; Nitriles; Prostatic Neoplasms; Sulfonamides; Thiohydantoins; Xenograft Model Antitumor Assays | 2010 |
Control of the proliferation of prostate cancer cells by an androgen and two antiandrogens. Cell specific sets of responses.
Topics: Androgen Antagonists; Cell Division; Cyproterone Acetate; Genes, myc; Humans; Imidazoles; Kinetics; Male; Metribolone; Nitriles; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; RNA, Messenger; Testosterone Congeners; Transcription, Genetic; Tumor Cells, Cultured | 1998 |